# Pathway Intermediates Limited

> Mediated Wiki article. Canonical URL: https://mediated.wiki/source/Pathway_Intermediates_Limited
> Markdown URL: https://mediated.wiki/source/Pathway_Intermediates_Limited.md
> Source: https://en.wikipedia.org/wiki/Pathway_Intermediates_Limited
> Source revision: 1305315634
> License: Creative Commons Attribution-ShareAlike 4.0 International (https://creativecommons.org/licenses/by-sa/4.0/)

{{Notability|Companies|date=October 2018}}

{{Use dmy dates|date=January 2015}}
{{Use British English|date=January 2015}}

'''Pathway Intermediates Limited''' (No. 04220119)<ref>http://www.companieshouse.gov.uk/ Companies House</ref> was founded in 2001 by cancer biologist<ref>Garnett, D.J. J Cancer Res Clin Oncol (2016) 142: 611. https://doi.org/10.1007/s00432-015-2074-3</ref> Dr David Garnett and mathematician Dr Robin Jones. The principal activity of the company is the manufacture of a class of specialty chemicals known as [biosurfactants](/source/Surfactant).

The company has its headquarters in [Shrewsbury](/source/Shrewsbury), United Kingdom with additional manufacturing sites in England and South Korea, along with offices in South Korea, USA, China, Thailand and Vietnam.{{Citation needed|date=October 2018}}

The company exports to Europe, Asia and the Americas. Significant growth in these markets was recognised in 2012 when the company won a [Queen's Awards for Enterprise](/source/Queen's_Awards_for_Enterprise).<ref>{{cite web |url=http://www.queensawardsmagazine.com/2012winners |title=2012 Winners &#124; the Queen's Awards for Enterprise Magazine |accessdate=2015-03-28 |url-status=dead |archiveurl=https://web.archive.org/web/20150115070201/http://www.queensawardsmagazine.com/2012winners |archivedate=15 January 2015 |df=dmy-all }} Queens Award for Enterprise</ref> In 2011 the company entered a joint venture agreement with Easy Bio Systems<ref>{{cite web|url=https://www.easybio.co.kr/eng |title=Easy Bio Inc KOREA |publisher=Easybio.co.kr |date= |accessdate=2019-02-19}}</ref> of South Korea and established a manufacturing company Pathway Intermediates International Inc,<ref>http://www.pathway-international.co.kr/ Pathway Intermediates International Inc</ref> located outside Seoul.<ref>[https://www.easybio.co.kr/Eng/01_info/easy_news_view.asp?pageLink=%26cate%3DE02%26gotopage%3D%26search_key%3D%26search_keyword%3D%26pidx%3D26 "Completion-of-LIPIDOL-plant-for-the-World-Markets!"] Easy Bio Inc News 20 March 2013</ref> In 2018 Easy Bio became the majority shareholder of Pathway Intermediates Limited.<ref>{{Cite web |title=Feedinfo - Pathway Intermediates Breaks Down The ‘Why’ Behind New US Business Unit & Upcoming Addition to Flagship Range – INDUSTRY PERSPECTIVES |url=https://www.feedinfo.com/our-content/pathway-intermediates-breaks-down-the-why-behind-new-us-business-unit-upcoming-addition-to-flagship-range-industry-perspectives/273211 |access-date=2024-07-26 |website=www.feedinfo.com}}</ref>

Pathway Intermediates Limited conducts research into novel lysophospholipids, [glycoside](/source/glycoside)s, [glyceride](/source/glyceride)s and other [ester](/source/ester)s and this work has attracted research grants from local and national government agencies.{{Citation needed|date=October 2018}}

==References==
{{Reflist}}

{{morecat|date=June 2024}}
Category:Companies based in Shropshire

---
Adapted from the Wikipedia article [Pathway Intermediates Limited](https://en.wikipedia.org/wiki/Pathway_Intermediates_Limited) by Wikipedia contributors ([contributor history](https://en.wikipedia.org/wiki/Pathway_Intermediates_Limited?action=history)). Available under [Creative Commons Attribution-ShareAlike 4.0 International](https://creativecommons.org/licenses/by-sa/4.0/). Changes may have been made.